雷梅西维尔用于治疗人类冠状病毒OC43脑炎
Jacques Fourgeaud1,2, Pascal Turlure3, Marine Dupont4
1Université Paris Cité, URP 7328 FETUS, Paris, France.
Journal of medical virology
|March 20, 2025
概括
人类冠状病毒OC43 (HCoV-OC43) 可以在免疫功能低下的个体中引起严重的脑炎. 这一案例突显了用雷梅西维尔治疗的成功,改善了神经功能.
科学领域:
- 神经病毒学 神经病毒学
- 传染性疾病 传染性疾病
- 关键护理医学 关键护理医学
背景情况:
- 人类冠状病毒OC43 (HCoV-OC43) 通常与轻度呼吸道疾病有关.
- HCoV-OC43具有神经侵入性能力,在免疫功能低下的患者中报告了严重的脑炎.
- 致命的结果与HCoV-OC43脑炎有关,这是由于缺乏向的抗病毒疗法.
研究的目的:
- 在免疫功能低下的患者中报告HCoV-OC43引起的严重发烧性脑炎病例.
- 描述抗病毒治疗的临床进展和反应.
主要方法:
- 一个65岁的免疫力受损的男性病例报告,神经系统逐渐衰退.
- 临床评估包括格拉斯哥昏迷评分 (GCS) 监测.
- 开始使用remdesivir的治疗.
主要成果:
- 患者出现了严重的发烧性脑炎,归因于HCoV-OC43,在3个月内恶化.
- 雷梅西维尔治疗导致显著的临床改善.
- 格拉斯哥昏迷评分在治疗7天内从8增加到14.
结论:
- HCoV-OC43可在免疫功能低下的个体中引起严重的渐进性脑炎.
- 雷梅西维尔在治疗由HCoV-OC43诱导的脑炎方面显示出潜在的疗效.
- 及时的抗病毒干预可以改善严重病例的神经结果.
相关概念视频
Acute Respiratory Failure-IV
115
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
115
Anticholinesterase Agents: Poisoning and Treatment
763
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
763
Pneumonia IV: Management
282
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
282
Acute Respiratory Failure-III
147
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
147
REM Sleep Behavior Disorder
127
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
127
Alzheimer's Disease: Treatment
139
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
139


